Sector pending / Medical LaboratoriesUpdated 2026-05-10 22:07 UTC

FRA/5GH stock hub

FRA/5GH has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/5GHis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

10.8B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/5GH

In the news

Latest news · FRA/5GH

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-21.7

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/5GH market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

162

Groups with data

Currency

USD

Showing 162 of 162 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	2,506
Employees Change	485%
Employees Change Percent	24
Enterprise value	EUR 11.3B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical Laboratories
Last refreshed	2026-05-10
Market cap	EUR 10.8B
Price	EUR 79.93
Price currency	EUR
Rev Per Employee	375,048.23x
Sic	8071
Symbol	fra/5GH
Website	https://guardanthealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.48%
EV Earnings	-30.06x
EV/FCF	-54.91x
EV/Sales	12.3x
FCF yield	-1.91%
P/B ratio	-68.65x
P/S ratio	11.51x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-41.39%
EBITDA Margin	-37.78%
Gross margin	64.9%
Gross Profit	EUR 608M
Gross Profit Growth	47.65%
Gross Profit Growth Q	52.81%
Gross Profit Growth3 Y	32.01%
Gross Profit Growth5 Y	28.89%
Net Income	EUR -375.7M
Pretax Margin	-40.21%
Profit Margin	-40.1%
Profit Per Employee	EUR -150,404
ROA	-17.15
Roa5y	-15.9
ROCE	-27.55
ROIC	-21.67

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	116.2%
Cagr3y	56.62%
Cagr5y	-5.59%
Revenue Growth	39.56x
Revenue Growth Q	48.26x
Revenue Growth3 Y	30.85x
Revenue Growth5 Y	29.39x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.66
Assets	EUR 1.7B
Cash	EUR 956.4M
Current Assets	EUR 1.2B
Current Liabilities	EUR 247.7M
Debt	EUR 1.5B
Debt FCF	EUR -7.19
Equity	EUR -157M
Interest Coverage	-83.85
Liabilities	EUR 1.8B
Long Term Assets	EUR 501.5M
Long Term Liabilities	EUR 1.6B
Net Cash	EUR -521.9M
Net Cash By Market Cap	EUR -4.84
Tangible Book Value	EUR -246.2M
Tangible Book Value Per Share	EUR -1.87

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.68
Inventory Turnover	4.71
Net Working Capital	EUR 546,399
Quick ratio	4.25
Working Capital	EUR 932.7M
Working Capital Turnover	EUR 1.05

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.2%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	116.09%
200-day SMA	71.94
3Y total return	284.28%
50-day SMA	75.88
50-day SMA vs 200-day SMA	50over200
5Y total return	-24.98%
All Time High	155.3
All Time High Change	-48.53%
All Time High Date	2021-02-15
All Time Low	15.02
All Time Low Change	432.16%
All Time Low Date	2024-04-22
ATR	2.06
Ch YTD	-6.71
High	79.93
High52	99.94
High52 Date	2026-01-22
High52ch	-20.02%
Low	79.93
Low52	32.52
Low52 Date	2025-05-23
Low52ch	145.79%
Ma50ch	5.34%
Price vs 200-day SMA	11.11%
RSI	57.89
RSI Monthly	60.48
RSI Weekly	53.27
Sharpe ratio	1.58x
Sortino ratio	2.62
Total Return	-3.2%
Tr YTD	-6.71
Tr1m	3.81%
Tr1w	7.25%
Tr3m	-6.14%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -387.8M
Operating margin	-41.39

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	127,179,439%
Net Borrowing	341,304,705
Shares Insiders	4.09%
Shares Institutions	98.91%
Shares Qo Q	2.03%
Shares Yo Y	3.2%
Short Ratio	5.81

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -358.4M
Average Volume	7x
Bv Per Share	-1.19
CAPEX	EUR -42.9M
Ch1m	3.81
Ch1w	7.25
Ch1y	116.1
Ch3m	-6.14
Ch3y	284.3
Ch5y	-24.98
Ch6m	-2.52
Change	2.25%
Change From Open	0
Close	78.17
Days Gap	2.25
Depreciation Amortization	33,021,336.2
Earnings Date	2026-05-07
EBIT	EUR -387.8M
EBITDA	EUR -354M
EPS	EUR -2.95
F Score	4
FCF	EUR -205.7M
FCF EV Yield	-1.82x
Financing CF	621,338,924
Fiscal Year End	December
Founded	2,011
Goodwill	65,511,000.2
Income Tax	EUR -1M
Investing CF	-200,041,010
Is Primary Listing	0
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Ma150	79.94
Ma150ch	-0.02%
Ma20	74.11
Ma20ch	7.86%
Net CF	258,098,072
Open	79.93
Ppne	257,730,418.2
Price Date	2026-05-08
Relative Volume	12.86x
Revenue	936,870,470x
SBC By Revenue	16.3x
Share Based Comp	152,703,776
Tax By Revenue	-0.11x
Tr6m	-2.52%
Volume	0
Z Score	0.82

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/5GH pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/5GH stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/5GH?

Insider, institutional, and short-interest positioning.

Institutional ownership

+98.9%

Share of float held by funds and institutions

Insider ownership

+4.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/5GH momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

57.9

Neutral momentum band

Price vs 200-day MA

+11.1%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.58

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/5GH

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/5GH stock rating?

fra/5GH is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/5GH analysis?

The full report lives at /stocks/fra/5GH/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/5GH?

The latest report frames fra/5GH around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/5GH page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.